Navigation Links
VIVEX BIOMEDICAL Successfully Completes $7.6 Million Round of Financing
Date:9/18/2013

MARIETTA, Ga., Sept. 18, 2013 /PRNewswire/ -- VIVEX BIOMEDICAL, INC., a biomaterials manufacturer and developer, announced today that it has successfully completed its first round of private equity financing.  The financing involved an over-subscribed offering of the Company's preferred stock, generating $7.6 million in start-up capital. 

Tracy Anderson, President and CEO of Vivex, said, "We are grateful to our shareholders and investors.  They have provided us capital to grow our rapidly expanding biosciences portfolio while allowing the executive team to focus on the strategic execution and day to day operations.  We are excited about the future of Vivex."

Start-up capital will be used to refine current and develop new products, expand its team, and identify and pursue strategic partnerships and other opportunities.  The company's patented flagship products, currently in development, include the MIAMI stem cell and mimetic pattern implants and other protected Intellectual Property.  The company's core biomaterials include demineralized bone matrix, sponge, allograft, and calcium phosphate products backed by a proprietary cleansing process that sustains bioactivity.

About VIVEX BIOMEDICAL, INC.

Vivex commenced operations in 2013 following a spin-off of the biomaterials division of Amendia, Inc., a Marietta, Georgia spinal implant manufacturer, and has since experienced rapid growth.  In support of the biologics-oriented platform, Vivex is developing a strategic portfolio of revolutionary interactive implants that nurture and guide the body's regenerative responses for accelerated healing while minimizing recuperation. The company's soon to be released flagship products range from bioresonant mimetic implants that encourage and enhance response from the body, to a revolutionary undifferentiated adult stem cell line that retains the multi-lineage potential to repair virtually any tissue type.

Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the federal security laws.  Forward-looking statements are only predictions and are not guarantees of performance.  You should not place undue reliance on any forward-looking statements.  

For more information, please visit the company's website at www.vivex.com or contact the company's General Counsel, Michael F. Rozmajzl, Esq., CPA., at 770.575.5221.  


'/>"/>
SOURCE VIVEX BIOMEDICAL, INC.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. New Reporting Guidelines For Case Reports Presented At The Congress On Peer Review And Biomedical Publication And Published In Seven Medical Journals
2. Saladax Biomedical Announces Addition to Leadership Team
3. Funding Tomorrow's Biomedical Research: California Healthcare Institute Hosts Pipeline for Life, July 15
4. The Galien Foundation Celebrates Biomedical Innovation in Fourth Galien Forum
5. David Julius Wins 2013 Dr. Paul Janssen Award for Biomedical Research
6. BioMedical Life Systems, Inc. Launches New FDA Cleared Non-Prescription TENS Device
7. Ondine Biomedical CEO Carolyn Cross Appointed Treasurer of International Photodynamic Association
8. Arteriocyte announces Launch of Compass Biomedical
9. Regenesis Biomedical Names Scott Brooks Chief Executive Officer
10. Premier Biomedical CEO Interviewed by The Wall Street Transcript
11. ICMs New Blue Gene Supercomputer Supports The Largest Biomedical Research Initiative In Poland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces a presentation by Subbu ... , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving ... marijuana products targeting the needs of consumers who are incorporating medical marijuana into ... in Phoenix, Arizona. , As operators of two successful Valley dispensaries, The Giving ...
Breaking Biology Technology:
(Date:4/18/2017)... 2017  Socionext Inc., a global expert in SoC-based imaging and ... the M820, which features the company,s hybrid codec technology. A demonstration ... Probe, Inc., will be showcased during the upcoming Medtec Japan at ... the Las Vegas Convention Center April 24-27. ... Click here for an ...
(Date:4/11/2017)... Apr. 11, 2017 Research and Markets has ... report to their offering. ... The global eye tracking market to grow at a CAGR of ... Eye Tracking Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
Breaking Biology News(10 mins):